Fundraising Fox

Biotech Pre-Seed Investors & VC Firms

896 firms in this list, with a median first check of $270K. 229 of them lead rounds. Generated from verified public data and updated continuously.

Artesian
AustraliaPre-Seed–Late Stage
42 people
Abingworth
LondonPre-Seed–Late Stage$15M – $30M
39 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
30 people
Jumpstart Ventures
ClevelandPre-Seed–Series A$500K – $2M
5 people
Agent Capital
WalthamPre-Seed–Late Stage
22 people
SOSV
New YorkPre-Seed–Series B$30K – $550K
29 people
Mission Biocapital
San FranciscoPre-Seed–Series A$500K
21 people
UntroD Capital
TokyoPre-Seed–Growth$772K – $241M
5 people
Medicxi
LondonPre-Seed–Late Stage
34 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
26 people
Bee Partners
LafayettePre-Seed–Seed$300K – $500K
9 people
Linear Capital
ShanghaiPre-Seed–Series A$1M – $10M
18 people
Everywhere Ventures
New YorkPre-Seed–Seed$250K
7 people
Nina Capital
BarcelonaPre-Seed–Series A$215K – $1.6M
21 people
2048 Ventures
New YorkPre-Seed–Seed$500K – $3M
11 people
Schmidt
SeoulPre-Seed–Growth
ZhenFund
BeijingPre-Seed–Series B$425K – $28M
27 people
Karista
ParisPre-Seed–Late Stage$324K – $5.4M
14 people
PMV
BrusselsPre-Seed–Late Stage
1 person
Trendlines Group
MisgavPre-Seed–Late Stage$650K – $15M
21 people
UTEC
TokyoPre-Seed–Growth$3.1M – $78M
1 person
Hoxton Ventures
LondonPre-Seed–Series B$500K – $5M
16 people
Launch NY
BuffaloPre-Seed–Seed$200K – $1M
4 people
Rho Ventures
New YorkPre-Seed–Late Stage$2M – $15M
10 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.